Patents by Inventor Erica Carrier

Erica Carrier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20230381147
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 10, 2023
    Publication date: November 30, 2023
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
    Publication number: 20230270726
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 10, 2023
    Publication date: August 31, 2023
    Inventors: Leo PAVLIV, Bryan VOSS, James West, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20220133696
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 14, 2022
    Publication date: May 5, 2022
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
    Publication number: 20210137895
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 17, 2021
    Publication date: May 13, 2021
    Inventors: Leo PAVLIV, Bryan VOSS, James West, Erica Carrier
  • Compositions and methods of treating cardiac fibrosis with ifetroban
    Patent number: 10925860
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: February 23, 2021
    Assignees: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, Bryan Voss, James West, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20210015798
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20200253935
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 30, 2020
    Publication date: August 13, 2020
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
    Publication number: 20200155512
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 27, 2020
    Publication date: May 21, 2020
    Inventors: Leo PAVLIV, Bryan VOSS, James West, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20200113872
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 11, 2019
    Publication date: April 16, 2020
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and methods of treating cardiac fibrosis with ifetroban
    Patent number: 10583126
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: March 10, 2020
    Assignees: CUMBERLAND PHARMACEUTICALS INC., Vanderbilt University
    Inventors: Leo Pavliv, Bryan Voss, James West, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20200030298
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: September 21, 2019
    Publication date: January 30, 2020
    Inventors: Leo PAVLIV, James WEST, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20190343809
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 28, 2019
    Publication date: November 14, 2019
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and methods of treating muscular dystrophy with thromboxane-Areceptor antagonists
    Patent number: 10456380
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: October 29, 2019
    Assignees: CUMBERLAND PHARMACEUTICLS INC., VANDERBILT UNIVERSITY
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
    Publication number: 20190247364
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 15, 2019
    Inventors: Leo PAVLIV, Bryan VOSS, James West, Erica Carrier
  • Compositions and methods of treating cardiac fibrosis with ifetroban
    Patent number: 10314824
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: June 11, 2019
    Assignees: Cumberland Pharmaceuticals Inc., Vanderbilt University
    Inventors: Leo Pavliv, Bryan Voss, James West, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20190142807
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: January 4, 2019
    Publication date: May 16, 2019
    Inventors: Leo PAVLIV, James WEST, Ines Macias-Perez, Erica Carrier
  • Ifetroban Treatment for Systemic Sclerosis
    Publication number: 20190117628
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating systemic sclerosis, by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 16, 2018
    Publication date: April 25, 2019
    Inventors: Leo PAVLIV, James West, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists
    Publication number: 20180353481
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Application
    Filed: July 31, 2018
    Publication date: December 13, 2018
    Inventors: Leo PAVLIV, James WEST, Ines Macias-Perez, Erica Carrier
  • Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
    Publication number: 20180344704
    Abstract: The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 11, 2018
    Publication date: December 6, 2018
    Inventors: Leo PAVLIV, Bryan VOSS, James West, Erica Carrier
  • Compositions and methods of treating muscular dystrophy with thromboxane-Areceptor antagonists
    Patent number: 10064845
    Abstract: The present invention is directed to methods of treating and/or ameliorating muscular dystrophy and/or treating cardiomyopathy in muscular dystrophy patients by administration of a therapeutically effective amount of a thromboxane A2 receptor antagonist.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: September 4, 2018
    Assignees: Cumberland Pharmaceuticals, Inc., Vanderbilt University
    Inventors: Leo Pavliv, James West, Ines Macias-Perez, Erica Carrier